Bio
Sarah has 20 years experience in research, drug development and business development in the biotech industry. As a biologist at Genentech she led teams that developed peptide and small molecule antagonists of cell adhesion from discovery through clinical trials. She was also a member of the development and launch teams for the Raptiva ®. antibody. Most recently Sarah was responsible for licensing at Schering-Plough Biopharma, the biologics subsidiary of Schering-Plough Corporation. Sarah received a B.Sc. in Molecular Biology from the University of Edinburgh, Scotland, a Ph.D. in Biology from the University of Lausanne, Switzerland and completed a Postdoctorate in Molecular Neurobiology at the Howard Hughes Medical Institute of the University of California at San Francisco.
Career
|
SV Life Sciences Advisers IncEmail: [email protected] |